🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/01/1980 1,93 1,99 1,93 1,99 +2,91% 3,60% 3.263.472
07/01/1980 1,92 1,96 1,92 1,93 +0,87% 2,25% 1.905.264
04/01/1980 1,91 1,94 1,91 1,92 +0,69% 1,73% 2.018.448
03/01/1980 1,88 1,90 1,84 1,90 +1,41% 3,18% 2.176.906
02/01/1980 1,92 1,93 1,87 1,88 -2,07% 2,77% 4.206.672
31/12/1979 1,94 1,94 1,92 1,92 -1,20% 1,54% 758.333
28/12/1979 1,94 1,94 1,93 1,94 -0,34% 0,68% 837.562
27/12/1979 1,92 1,94 1,92 1,94 +1,20% 1,20% 830.016
26/12/1979 1,93 1,93 1,92 1,92 -0,51% 0,68% 762.106
24/12/1979 1,94 1,94 1,93 1,93 -0,85% 0,85% 596.102
21/12/1979 1,94 1,95 1,94 1,95 +0,86% 0,35% 1.222.387
20/12/1979 1,91 1,93 1,91 1,93 +1,22% 1,21% 2.139.178
19/12/1979 1,92 1,92 1,90 1,91 -0,34% 1,04% 3.116.333
18/12/1979 1,94 1,95 1,92 1,92 -1,36% 1,71% 3.022.013
17/12/1979 1,95 1,96 1,93 1,94 -0,34% 1,70% 2.920.147
14/12/1979 1,91 1,95 1,91 1,95 +2,44% 2,09% 3.655.843
13/12/1979 1,91 1,92 1,90 1,90 -0,17% 1,04% 1.478.938
12/12/1979 1,92 1,92 1,90 1,91 -0,86% 0,69% 2.222.179
11/12/1979 1,94 1,94 1,92 1,92 -1,02% 1,36% 2.448.547
10/12/1979 1,95 1,95 1,91 1,94 -0,51% 2,04% 2.154.269
07/12/1979 1,95 1,97 1,95 1,95 +0,17% 1,02% 3.293.654
06/12/1979 1,92 1,95 1,92 1,95 +1,91% 1,73% 2.252.362
05/12/1979 1,92 1,93 1,91 1,91 -0,34% 1,38% 1.622.304
04/12/1979 1,90 1,93 1,89 1,92 +1,22% 1,75% 2.041.085
03/12/1979 1,91 1,91 1,89 1,90 -1,21% 0,87% 1.524.211
30/11/1979 1,94 1,94 1,92 1,92 -1,36% 1,03% 1.901.491
29/11/1979 1,96 1,96 1,93 1,94 -0,68% 1,35% 1.063.930
28/11/1979 1,93 1,96 1,91 1,96 +1,20% 2,40% 1.516.666
27/11/1979 1,94 1,96 1,93 1,93 -0,17% 1,54% 2.033.539
26/11/1979 1,89 1,95 1,89 1,94 +3,35% 3,51% 3.927.485